Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice

Ryozo Oishi, Miwa Baba, Masahiro Nishibori, Yoshinori Itoh, Kiyomi Saeki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Morphine (5 mg/kg, s.c.) caused a submaximal increase in the brain level of sodium fluorescein administered i.v. Histamine H1-antagonists, diphenhydramine and mepyramine, given either i.p. or i.c.v., had no significant influence on the effect of morphine. H2-Antagonists, cimetidine and ranitidine, administered i.c.v., but not i.p., significantly inhibited the morphine effect. α-Fluoromethylhistidine, a specific histidine decarboxylase inhibitor (given i.p. and i.e.v.) and antimuscarinic drugs, atropine and biperiden, but not methylatropine (given i.p.) also significantly reduced the morphine effect. Physostigmine (i.p.) significantly enhanced the effects of 0.5 and 1 mg/kg of morphine. Similar effects of histaminergic and cholinergic drugs were also observed on the buprenorphine- and DAGO-induced increase in blood-brain barrier (BBB) permeability to sodium fluorescein. None of the treatments with 6-hydroxydopamine, α-methylayrosine, 5,7-dihydroxytryptamine or p-chlorophenylamine had any significant effect on the morphine-induced increase in BBB permeability. These findings suggest that the activation of brain H2-receptors by neuronal histamine and muscarinic receptors by acetylcholine is involved in the increase in BBB permeability to sodium fluorescein caused by μ opioid receptor agonists.

Original languageEnglish
Pages (from-to)159-165
Number of pages7
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume339
Issue number1
DOIs
Publication statusPublished - 1989

Fingerprint

Blood-Brain Barrier
Fluorescein
Morphine
Cholinergic Agents
Permeability
Biperiden
Histamine Agents
5,7-Dihydroxytryptamine
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Histamine H1 Antagonists
Histidine Decarboxylase
Pyrilamine
Diphenhydramine
Histamine Receptors
Buprenorphine
Histamine H2 Receptors
Physostigmine
Muscarinic Antagonists
Ranitidine
Oxidopamine

Keywords

  • Blood-brain-barrier
  • H-Receptors
  • Histamine
  • Morphine
  • Sodium fluorescein

ASJC Scopus subject areas

  • Pharmacology

Cite this

Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice. / Oishi, Ryozo; Baba, Miwa; Nishibori, Masahiro; Itoh, Yoshinori; Saeki, Kiyomi.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 339, No. 1, 1989, p. 159-165.

Research output: Contribution to journalArticle

@article{04f5c83a50cb436aa67c61fa8ba595dd,
title = "Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice",
abstract = "Morphine (5 mg/kg, s.c.) caused a submaximal increase in the brain level of sodium fluorescein administered i.v. Histamine H1-antagonists, diphenhydramine and mepyramine, given either i.p. or i.c.v., had no significant influence on the effect of morphine. H2-Antagonists, cimetidine and ranitidine, administered i.c.v., but not i.p., significantly inhibited the morphine effect. α-Fluoromethylhistidine, a specific histidine decarboxylase inhibitor (given i.p. and i.e.v.) and antimuscarinic drugs, atropine and biperiden, but not methylatropine (given i.p.) also significantly reduced the morphine effect. Physostigmine (i.p.) significantly enhanced the effects of 0.5 and 1 mg/kg of morphine. Similar effects of histaminergic and cholinergic drugs were also observed on the buprenorphine- and DAGO-induced increase in blood-brain barrier (BBB) permeability to sodium fluorescein. None of the treatments with 6-hydroxydopamine, α-methylayrosine, 5,7-dihydroxytryptamine or p-chlorophenylamine had any significant effect on the morphine-induced increase in BBB permeability. These findings suggest that the activation of brain H2-receptors by neuronal histamine and muscarinic receptors by acetylcholine is involved in the increase in BBB permeability to sodium fluorescein caused by μ opioid receptor agonists.",
keywords = "Blood-brain-barrier, H-Receptors, Histamine, Morphine, Sodium fluorescein",
author = "Ryozo Oishi and Miwa Baba and Masahiro Nishibori and Yoshinori Itoh and Kiyomi Saeki",
year = "1989",
doi = "10.1007/BF00165138",
language = "English",
volume = "339",
pages = "159--165",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice

AU - Oishi, Ryozo

AU - Baba, Miwa

AU - Nishibori, Masahiro

AU - Itoh, Yoshinori

AU - Saeki, Kiyomi

PY - 1989

Y1 - 1989

N2 - Morphine (5 mg/kg, s.c.) caused a submaximal increase in the brain level of sodium fluorescein administered i.v. Histamine H1-antagonists, diphenhydramine and mepyramine, given either i.p. or i.c.v., had no significant influence on the effect of morphine. H2-Antagonists, cimetidine and ranitidine, administered i.c.v., but not i.p., significantly inhibited the morphine effect. α-Fluoromethylhistidine, a specific histidine decarboxylase inhibitor (given i.p. and i.e.v.) and antimuscarinic drugs, atropine and biperiden, but not methylatropine (given i.p.) also significantly reduced the morphine effect. Physostigmine (i.p.) significantly enhanced the effects of 0.5 and 1 mg/kg of morphine. Similar effects of histaminergic and cholinergic drugs were also observed on the buprenorphine- and DAGO-induced increase in blood-brain barrier (BBB) permeability to sodium fluorescein. None of the treatments with 6-hydroxydopamine, α-methylayrosine, 5,7-dihydroxytryptamine or p-chlorophenylamine had any significant effect on the morphine-induced increase in BBB permeability. These findings suggest that the activation of brain H2-receptors by neuronal histamine and muscarinic receptors by acetylcholine is involved in the increase in BBB permeability to sodium fluorescein caused by μ opioid receptor agonists.

AB - Morphine (5 mg/kg, s.c.) caused a submaximal increase in the brain level of sodium fluorescein administered i.v. Histamine H1-antagonists, diphenhydramine and mepyramine, given either i.p. or i.c.v., had no significant influence on the effect of morphine. H2-Antagonists, cimetidine and ranitidine, administered i.c.v., but not i.p., significantly inhibited the morphine effect. α-Fluoromethylhistidine, a specific histidine decarboxylase inhibitor (given i.p. and i.e.v.) and antimuscarinic drugs, atropine and biperiden, but not methylatropine (given i.p.) also significantly reduced the morphine effect. Physostigmine (i.p.) significantly enhanced the effects of 0.5 and 1 mg/kg of morphine. Similar effects of histaminergic and cholinergic drugs were also observed on the buprenorphine- and DAGO-induced increase in blood-brain barrier (BBB) permeability to sodium fluorescein. None of the treatments with 6-hydroxydopamine, α-methylayrosine, 5,7-dihydroxytryptamine or p-chlorophenylamine had any significant effect on the morphine-induced increase in BBB permeability. These findings suggest that the activation of brain H2-receptors by neuronal histamine and muscarinic receptors by acetylcholine is involved in the increase in BBB permeability to sodium fluorescein caused by μ opioid receptor agonists.

KW - Blood-brain-barrier

KW - H-Receptors

KW - Histamine

KW - Morphine

KW - Sodium fluorescein

UR - http://www.scopus.com/inward/record.url?scp=0024533091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024533091&partnerID=8YFLogxK

U2 - 10.1007/BF00165138

DO - 10.1007/BF00165138

M3 - Article

C2 - 2566923

AN - SCOPUS:0024533091

VL - 339

SP - 159

EP - 165

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 1

ER -